Lineage Cell Therapeutics (AMEX:LCTX) is gearing up to announce its quarterly earnings on Thursday, 2024-11-14. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.04.

Anticipation surrounds Lineage Cell Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Past Earnings Performance

The company's EPS beat by $0.01 in the last quarter, leading to a...